Medicines Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies By Helena Musk / May 18, 2022
Weight Loss Programs What We Know About Eli Lilly’s Experimental Weight-Loss Drug By Helena Musk / May 16, 2022
Weight Loss Programs Hunger-blocking new obesity drug achieves 24 kg of average weight loss By Helena Musk / May 12, 2022
Medicines Pharmacists in England face abuse from patients due to drug shortages | Health By Helena Musk / April 25, 2022
